Panagiotis Zikos

585 total citations
26 papers, 306 citations indexed

About

Panagiotis Zikos is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, Panagiotis Zikos has authored 26 papers receiving a total of 306 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Hematology, 7 papers in Molecular Biology and 7 papers in Genetics. Recurrent topics in Panagiotis Zikos's work include Acute Myeloid Leukemia Research (13 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (6 papers) and Multiple Myeloma Research and Treatments (5 papers). Panagiotis Zikos is often cited by papers focused on Acute Myeloid Leukemia Research (13 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (6 papers) and Multiple Myeloma Research and Treatments (5 papers). Panagiotis Zikos collaborates with scholars based in Greece, United States and Italy. Panagiotis Zikos's co-authors include Maria Teresa Van Lint, Mario Sessarego, Andrea Bacigalupo, Giovanni Berisso, Alice Maniatis, Francesco Frassoni, Anastasia Bougea, Anna Pitto, Giovanna Piaggio and Marina Podestà and has published in prestigious journals such as Blood, Annals of Oncology and American Journal of Hematology.

In The Last Decade

Panagiotis Zikos

24 papers receiving 301 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Panagiotis Zikos Greece 10 212 97 91 87 28 26 306
Xinping Zhou China 8 152 0.7× 92 0.9× 96 1.1× 57 0.7× 25 0.9× 43 290
Francesca Vendemini Italy 10 121 0.6× 136 1.4× 34 0.4× 54 0.6× 23 0.8× 16 302
Vera Otten Netherlands 5 238 1.1× 60 0.6× 97 1.1× 71 0.8× 174 6.2× 7 435
Nicole Engel Germany 12 153 0.7× 61 0.6× 30 0.3× 92 1.1× 44 1.6× 21 366
María Antonia Durán Spain 9 145 0.7× 84 0.9× 114 1.3× 29 0.3× 23 0.8× 28 258
Xina Graehlert Germany 5 284 1.3× 72 0.7× 47 0.5× 30 0.3× 41 1.5× 7 390
Emma Gudgin United Kingdom 11 124 0.6× 95 1.0× 115 1.3× 18 0.2× 24 0.9× 16 234
Soumitra Tole Canada 9 50 0.2× 104 1.1× 33 0.4× 30 0.3× 65 2.3× 20 339
Giulia Ceglie Italy 11 63 0.3× 64 0.7× 115 1.3× 17 0.2× 19 0.7× 22 261
Ekaterina Balaian Germany 9 100 0.5× 65 0.7× 80 0.9× 35 0.4× 22 0.8× 16 208

Countries citing papers authored by Panagiotis Zikos

Since Specialization
Citations

This map shows the geographic impact of Panagiotis Zikos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Panagiotis Zikos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Panagiotis Zikos more than expected).

Fields of papers citing papers by Panagiotis Zikos

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Panagiotis Zikos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Panagiotis Zikos. The network helps show where Panagiotis Zikos may publish in the future.

Co-authorship network of co-authors of Panagiotis Zikos

This figure shows the co-authorship network connecting the top 25 collaborators of Panagiotis Zikos. A scholar is included among the top collaborators of Panagiotis Zikos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Panagiotis Zikos. Panagiotis Zikos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Konitsiotis, Spyridon, Athanasia Alexoudi, Panagiotis Zikos, et al.. (2024). Paradigm shift in Parkinson's disease: using continuous telemonitoring to improve symptoms control. Results from a 2-years journey. Frontiers in Neurology. 15. 1415970–1415970. 2 indexed citations
2.
3.
4.
Papageorgiou, Sotirios G., Christos K. Kontos, Ιoannis Kotsianidis, et al.. (2019). Effectiveness of 5-Azacytidine in older patients with high-risk myelodysplastic syndromes and oligoblastic acute myeloid leukemia: A retrospective analysis of the Hellenic (Greek) MDS Study Group. Journal of Geriatric Oncology. 11(1). 121–124. 4 indexed citations
5.
Symeonidis, Argiris, Sotirios G. Papageorgiou, Maria Melachrinou, et al.. (2019). Primary Bone Non-Hodgkin's Lymphoma: A Specific Clinical Entity with Aggressive Clinical Course and High Cure Rate - Retrospective Analysis of 102 Patients from Greece. Blood. 134(Supplement_1). 5340–5340. 1 indexed citations
6.
Papageorgiou, Sotirios G., Diamantina Vasilatou, Christos K. Kontos, et al.. (2018). The prognostic value of monosomal karyotype (MK) in higher‐risk patients with myelodysplastic syndromes treated with 5‐Azacitidine: A retrospective analysis of the Hellenic (Greek) Myelodysplastic syndromes Study Group. American Journal of Hematology. 93(7). 895–901. 9 indexed citations
7.
Papageorgiou, Sotirios G., Christos K. Kontos, Ιoannis Kotsianidis, et al.. (2018). The outcome of patients with high‐risk MDS achieving stable disease after treatment with 5‐azacytidine: A retrospective analysis of the Hellenic (Greek) MDS Study Group. Hematological Oncology. 36(4). 693–700. 7 indexed citations
8.
Costeas, Paul, et al.. (2018). Ectopic Lck expression in CLL demarcates intratumoral subpopulations with aberrant B-cell receptor signaling. Blood Advances. 2(8). 877–882. 4 indexed citations
9.
10.
Avgerinou, Christina, et al.. (2017). Occupational, dietary, and other risk factors for myelodysplastic syndromes in Western Greece. Hematology. 22(7). 419–429. 16 indexed citations
11.
Pappa, Vasiliki, Αchilles Anagnostopoulos, Evangelos Briasoulis, et al.. (2016). A retrospective study of azacitidine treatment in patients with intermediate-2 or high risk myelodysplastic syndromes in a real-world clinical setting in Greece. International Journal of Hematology. 105(2). 184–195. 2 indexed citations
12.
Sakellaropoulos, George, Ioannis Starakis, Panagiotis Zikos, et al.. (2015). Evaluation of a Bone Marrow Dysmyelopoiesis Immunophenotypic Index for the Diagnosis and Prognosis of Myelodysplastic Syndromes. Cardiovascular & Haematological Disorders - Drug Targets. 15(2). 148–161. 3 indexed citations
13.
Avgerinou, Christina, Yannis Alamanos, Panagiotis Zikos, et al.. (2013). The incidence of myelodysplastic syndromes in Western Greece is increasing. Annals of Hematology. 92(7). 877–887. 24 indexed citations
14.
Symeonidis, Argiris, Panagiotis Zikos, Athanasios Galanopoulos, et al.. (2011). 319 Response to treatment with erythropoietin in patients with MDS highly predicts low risk of evolution to AML and longer survival. Leukemia Research. 35. S127–S128. 2 indexed citations
15.
Zervas, Konstantinos, Dimitra Mihou, Eirini Katodritou, et al.. (2007). VAD-doxil versus VAD-doxil plus thalidomide as initial treatment for multiple myeloma: results of a multicenter randomized trial of the Greek myeloma study group. Annals of Oncology. 18(8). 1369–1375. 53 indexed citations
16.
Symeonidis, Argiris, Alexandra Kouraklis‐Symeonidis, Panagiotis Zikos, et al.. (2007). P140 Factors predicting for a favorable response among patients with myelodysplastic syndromes treated with erythropoietin ± G-CSF. Leukemia Research. 31. S116–S117. 2 indexed citations
17.
Matsouka, Panagiota, Maria Pagoni, Panagiotis Zikos, et al.. (2006). Addition of cyclosporin-A to chemotherapy in secondary (post-MDS) AML in the elderly. A multicenter randomized trial of the Leukemia Working Group of the Hellenic Society of Hematology. Annals of Hematology. 85(4). 250–256. 16 indexed citations
18.
Zervas, Konstantinos, Dimitra Mihou, Anastasia Pouli, et al.. (2006). VAD-doxil vs.VAD-doxil Plus Thalidomide as Initial Treatment in Patients with Multiple Myeloma: A Multicenter Randomized Trial of the Greek Myeloma Study Group.. Blood. 108(11). 794–794. 7 indexed citations
19.
Καρακάντζα, Μαρίνα, Nikolaos Giannakoulas, Panagiotis Zikos, et al.. (2004). Markers of Endothelial and In Vivo Platelet Activation in Patients with Essential Thrombocythemia and Polycythemia Vera. International Journal of Hematology. 79(3). 253–259. 30 indexed citations
20.
Paterakis, George, et al.. (2001). Expression of Granzyme B and Perforin in Multiple Myeloma. Acta Haematologica. 105(3). 125–129. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xinping Zhou Breakdown of academic impact, for papers by Francesca Vendemini Breakdown of academic impact, for papers by Vera Otten Breakdown of academic impact, for papers by Nicole Engel Breakdown of academic impact, for papers by María Antonia Durán Breakdown of academic impact, for papers by Xina Graehlert Breakdown of academic impact, for papers by Emma Gudgin Breakdown of academic impact, for papers by Soumitra Tole Breakdown of academic impact, for papers by Giulia Ceglie Breakdown of academic impact, for papers by Ekaterina Balaian
Rankless by CCL
2026